• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulation of Synthesis and Degradation of Extracellular Matrix in Acute Myocardial Infarction

Research Project

Project/Area Number 11670691
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

MAKINO Naoki (2000)  Medical Institute of Bioregulation Kyushu Univ. Professors, 生体防御医学研究所, 教授 (60157170)

畑 知二 (1999)  九州大学, 生体防御医学研究所, 講師 (90198739)

Co-Investigator(Kenkyū-buntansha) SATOH Shinji  Medical Institute of Bioregulation Kyushu Univ.Assistant Professors, 生体防御医学研究所, 講師 (60274445)
YANO Kenichi  Medical Institute of Bioregulation Kyushu Univ.Research Associates, 生体防御医学研究所, 助手 (60230281)
牧野 直樹  九州大学, 生体防御医学研究所, 教授 (60157170)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2000: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 1999: ¥1,700,000 (Direct Cost: ¥1,700,000)
Keywordsmyocardial infarction / Extracellular Matrix / Myocardial Fibrosis / Tissue Necrosis Factor / matrix metaloproteinase / コラーゲン / メタロプロテアーゼ
Research Abstract

ABSTRACT
Previous studies suggest that the balance between matrix metalloproteinase (MMPs) and tissue inhibitors of matrix metallotroteinases (TIMP) abundance were important in the setting of dilated cardiomyopathy. The synthesis of MMPs is also regulated by a number of cytokines and growth factors. The present study was undertaken to examine whether tumor necrosis factor-a (TNF-a) preceded in infarcted myocardium in prior to expressions of MMPs and TIMPs and whether those expressions and activations mediate many of the morphological changes that occur after myocardial infarction (MI) at both infarcted and non-infarcted regions. MI was induced by surgical occlusion of the left main coronary artery in rats. Collagen content in infarct zone increased four folds at the first week, while in the non- infarct zone this content increased two folds at the first week. By the RT-PCR method, mRNAs levels for MMP-13 and MMP-2 were both enhanced at day 7 to day 14 and thereafter decreased at day 28. MMP-3 and MMP-14 mRNA expressions were more expressed at day 14 and 28 after MI.MMP-9 mRNA expression also increased from day 1 to day 7. The levels of TIMP-1 and TIMP-2 mRNA expressions were elevated within 1 week and thereafter reduced. TIMP-3 mRNA was more expressed from day 14. TNF-a mRNA in the infarct zone increased from day 2 to day 7 although those levels were still elevated to day 28. The maximal TNF-a protein levels (7-fold increase) were day 7 in the infarct zone. Thus, MMP-9 (neutrophil gelatinase) was co-expressed with TNF-a at early phase after MI and other MMPs and TIMPs were then expressed within one week. Immunohistochemical study in infarct zone was also evaluated as seen in results of gene and protein expressions. Present results therefore suggest that TNF-a secreted from neutrophils in infarct zone after MI may precede in infarcted myocardium in prior to the expression of other matrix degradative enzymes.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Makino N,Sugano M,Otsuka S,Sawada S,Hata T.: "Chronic antosense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats"Cardiovasc.Research. 44. 543-548 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Masutomo K,Makino N,Sugano M,Miyamoto S,Hata T,Yanaga Y: "Extracellular Matrix Regulation in the Development of Syrian Cardiomyopathic Bio 14.6 and Bio 53.58 Hamsters"J Mol Cell Cardiol.. 31. 1607-1615 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Dhalla NS,Elmoselhi AB,Hata T,Makino N.: "Status of myocardial antioxidants in ischemic-reperfusion injury"Cardiovasc Res. 47. 446-456 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirayama H,Sugano M,Abe N,Yonemochi H,Makino N.: "Triglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients."International Journal of Cardiol.. 77. 75-79 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sugano M,Tsuchida K,Sawada S,Makino N.: "Reduction of plasma angiotensin II to normal level by antisense oligodeoxynucleotides against liver angiotensinogen can not completely attenuate vascular remodeling in spontaneously hypertensive rats."J.Hypertension.. 18. 725-731 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Makino N, Sugano M, Otsuka S, SawadaS, Hata T.: "Chronic antosense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats."Cardiovasc. Research. 44. 543-548 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Masutomo K, Makino N, Sugano M, Miyamoto S, Hata T, Yanaga Y: "Extracellular Matrix Regulation in the Development of Syrian Cardiomyopathic Bio 14.6 and Bio 53.58 Hamsters."J Mol Cell Cardiol.. 31. 1607-1615 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Dhalla NS, Elmoselhi AB, Hata T, Makino N: "Status of myocardial antioxidants in ischemic-reperfusion injury."Cardiovasc Res. 47. 446-456 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirayama H, Sugano M, Abe N, Yonemochi H, Makino N.: "Determination of left ventricular mass by echocardiography in normotensive diabetic patients."Jap Circ J. 64. 921-924 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirayama H, Sugano M, Abe N, Yonemochi H, Makino N.: "Triglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients."International Journal of Cardiol.. 77. 75-79 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Makino N,Sugano M,Otsuka S,Sawada S,Hata T.: "Chronic antosense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats"Cardiovasc.Research. 44. 543-548 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Masutomo K,Makino N,Sugano M,Miyamoto S,Hata T,Yanaga Y: "Extracellular Matrix Regulation in the Development of Syrian Cardiomyopathic Bio 14.6 and Bio 53.58 Hamsters"J Mol Cell Cardiol.. 31. 1607-1615 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Dhalla NS,Elmoselhi AB,Hata T,Makino N.: "Status of myocardial antioxidants in ischemic-reperfusion injury"Cardiovasc Res. 47. 446-456 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hirayama H,Sugano M,Abe N,Yonemochi H,Makino N.: "Triglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients."International Journal of Cardiol.. 77. 75-79 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Sugano M,Tsuchida K,Sawada S,Makino N.: "Reduction of plasma angiotensin II to normal level by antisense oligodeoxynucleotides against liver angiotensinogen can not completely attenuate vascular remodeling in spontaneously hypertensive rats."J.Hypertension.. 18. 725-731 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Otsuka S,Sugano M,Makino N,Sawada S,Hata T,Niho Y.: "Interaction of mRNAs for Angiotensin II Type 1 and Type 2 Receptors to Vascular Remodelling in Spontaneously Hypertensive Rats"Hypertension.. 32. 467-472 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Masutomo,K.,Makino,N.,Sugano,M.,Mityamoto,S.,Hata,T.,Yanaga,T.: "Extracellular matrix regulation in the development of Syrian cardiomyopathic Bio4.6 and Bio 53.58 hamsters"J Mol Cell Cardiol.. 31. 1607-1615 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Makino N.,Sugano M,Otsuka S.,Sawada S.,Hata T.: "Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats"Cardiovasc Res. 44. 543-548 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi